On the move, page-36

Anteo's Diagnostic tests are 10 to 16% more benefit in sensitivity , also the fastest trop0nin test by far available at under 10 minutes , what is that worth to big pharma at only $17 million MC is peanuts .

During the year Planet Innovation (“PI” announced that their PoC diagnostic test system showed a 10-16X benefit in sensitivity over a current on-market benchmark. PI's integrated diagnostic system uses AnteoBindTM conjugates in conjunction with PI's novel reader and cartridge technology, PI patented membrane technology and also features design inputs from additional collaborators.

The excellent technical results led the Company to conclude that AnteoBindTM provides commercial benefits to the Lateral Flow market. During the year and up to the date of this report a representative mix of assays including Infectious Disease, Fertility and Cardiac Care were chosen to highlight performance improvement across a range of diagnostically important segments.

In addition, several particle types were selected from different manufacturers to assess AnteoBindTM compatibility across a range of supplier platforms. The objective of developing these prototype stage assays was to build a comprehensive package of validation data that would clearly highlight the improvements AnteoBindTM can deliver if incorporated in fully commercialized Lateral Flow assays. It is was also opportunity to highlight the value of AnteoBindTM activated particles as a viable input component in the development of PoC Lateral Flow assay kits